270 related articles for article (PubMed ID: 15221581)
1. Management of opioid-induced bowel dysfunction in cancer patients.
Tamayo AC; Diaz-Zuluaga PA
Support Care Cancer; 2004 Sep; 12(9):613-8. PubMed ID: 15221581
[TBL] [Abstract][Full Text] [Related]
2. Incidence, prevalence, and management of opioid bowel dysfunction.
Pappagallo M
Am J Surg; 2001 Nov; 182(5A Suppl):11S-18S. PubMed ID: 11755892
[TBL] [Abstract][Full Text] [Related]
3. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden.
Panchal SJ; Müller-Schwefe P; Wurzelmann JI
Int J Clin Pract; 2007 Jul; 61(7):1181-7. PubMed ID: 17488292
[TBL] [Abstract][Full Text] [Related]
4. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
Foss JF
Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
[TBL] [Abstract][Full Text] [Related]
5. Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.
Paulson DM; Kennedy DT; Donovick RA; Carpenter RL; Cherubini M; Techner L; Du W; Ma Y; Schmidt WK; Wallin B; Jackson D
J Pain; 2005 Mar; 6(3):184-92. PubMed ID: 15772912
[TBL] [Abstract][Full Text] [Related]
6. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
Yuan CS
J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
[TBL] [Abstract][Full Text] [Related]
7. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.
Leppert W
Drug Des Devel Ther; 2015; 9():2215-31. PubMed ID: 25931815
[TBL] [Abstract][Full Text] [Related]
8. [Treament of morphine-induced constipation with oral naloxone].
Latasch L; Zimmermann M; Eberhardt B; Jurna I
Anaesthesist; 1997 Mar; 46(3):191-4. PubMed ID: 9163262
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
[TBL] [Abstract][Full Text] [Related]
10. Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist.
Schmidt WK
Am J Surg; 2001 Nov; 182(5A Suppl):27S-38S. PubMed ID: 11755894
[TBL] [Abstract][Full Text] [Related]
11. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
Streicher JM; Bilsky EJ
J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
[TBL] [Abstract][Full Text] [Related]
12. Oral naloxone reverses opioid-associated constipation.
Meissner W; Schmidt U; Hartmann M; Kath R; Reinhart K
Pain; 2000 Jan; 84(1):105-109. PubMed ID: 10601678
[TBL] [Abstract][Full Text] [Related]
13. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
Yuan CS
Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
[TBL] [Abstract][Full Text] [Related]
14. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
15. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).
Bell TJ; Panchal SJ; Miaskowski C; Bolge SC; Milanova T; Williamson R
Pain Med; 2009 Jan; 10(1):35-42. PubMed ID: 18721170
[TBL] [Abstract][Full Text] [Related]
16. An overview of constipation and newer therapies.
Enck RE
Am J Hosp Palliat Care; 2009; 26(3):157-8. PubMed ID: 19531698
[No Abstract] [Full Text] [Related]
17. [Treatment of constipation in chronic pain patients].
Shimoyama N; Shimoyama M
Masui; 2013 Jul; 62(7):822-8. PubMed ID: 23905405
[TBL] [Abstract][Full Text] [Related]
18. The relationship between opioid use and laxative use in terminally ill cancer patients.
Sykes NP
Palliat Med; 1998 Sep; 12(5):375-82. PubMed ID: 9924600
[TBL] [Abstract][Full Text] [Related]
19. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
Baker DE
Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
[TBL] [Abstract][Full Text] [Related]
20. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management.
Holzer P; Ahmedzai SH; Niederle N; Leyendecker P; Hopp M; Bosse B; Spohr I; Reimer K
J Opioid Manag; 2009; 5(3):145-51. PubMed ID: 19662924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
